查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1542898

全球非侵入性血压计市场 - 2024-2031

Global Non-Invasive Blood Pressure Monitors Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球非侵入性血压计市场规模达到24.305亿美元，预计到2031年将达到53.5315亿美元，2024-2031年预测期间复合年增长率为10.71%。

血压计在医院中用于测量重症患者或将要进行任何外科手术的患者的血压。血压计用于手术室、重症监护室、手术恢復室、急诊室和其他重症监护区域定期或连续测量血压。在患者病情危急期间检查血压，因为它在诊断中起着重要作用。

非侵入性血压计市场动态

全球高血压和心血管疾病的兴起以及政府的控制、老年人口的增加以及非侵入性血压监测仪的技术进步是预测期内推动市场的因素。

正在进行的非侵入性血压监测仪研究预计将推动市场成长。

BPro（Healthstats，新加坡）是一款用于动态血压测量的腕錶式桡动脉血压计。首先用臂套装置对其进行校准。手錶在校准后至少 24 小时内提供准确的结果。该装置包括一个带有简单图形使用者介面的表头和一个压在桡动脉上的柱塞。医疗保健专业人员将柱塞粘在手腕上进行校准，以防止使用时移动。该设备已通过 AAMI 和 ESH 标准的验证，SBP 和 DBP 读数分别为 (0.9 - 7.6) mmHg 和 (1.1 - 6.1) mmHg。

此外，图尔库大学的研究小组在 2020 年提出了一种桌上型血压仪，即手指动脉非侵入性血压监测仪 (FANTOM)。张力测量无袖带机电系统用于向指尖施加压力并使用示波法测量血压。该设备可以测量动脉波形和中心血压（CBP）。将此设备与自动臂带监测仪进行比较的任意验证协议产生的 SBP 和 DBP 结果分别为 (0.9 ± 7.3) mmHg 和 (3.3 ± 6.6) mmHg。因此，正在进行的无袖带无创血压监测仪的研究预计将在预测期内得到推动。

无创血压测量的缺点预计将阻碍市场成长。

非侵入性血压测量在极端压力下可靠性较差，且无法连续监测；如果设定重复得太频繁，并且需要手动操作以获得最大精度（即，自动模式对于不稳定的患者来说不可靠），这可能会很痛苦。因此，综合上述因素，预计市场在预测期内将受到阻碍。

COVID-19 对非侵入性血压监测仪市场成长的影响

COVID-19 大流行对非侵入性血压监测仪市场产生了适度影响。专家意识到，当全球范围内的病毒病例开始上升时，COVID-19 对患有心臟病和相关疾病的人尤其危险，尤其是患有高血压的人。美国一亿三百万成年人（即近一半成年人）患有高血压，也称为高血压。更令人担忧的是，只有四分之一的成年人的血压得到控制。血压不受控制会导致心臟病和中风等严重併发症。随着 COVID-19 疫情的持续爆发，一个新问题出现了。高血压患者可能容易受到更致命和更严重的冠状病毒副作用的影响。因此，现在对非侵入性血压计的需求越来越大。

此外，COVID-19 还有另一个潜在的有害影响。这导致许多患者避开当地医院和急诊室，因为他们可能会感染冠状病毒。全国各地的医院报告紧急医疗需求的就诊人数减少。儘管如此，一些专家认为这并不是因为患者经历的次数减少，而是因为他们推迟或推迟寻求治疗。因此，从上述因素来看，市场受到影响，预计在预测期内将有所改善。

非侵入性血压计市场细分

预计数位细分市场将在非侵入性血压监测仪中占据最大的市场份额

2021 年，数位细分市场占据最大市场份额。它们非常适合在家中使用，特别是在患者测量血压的情况下。他们采用电子压力感测器来协助测量血压。结果，读数以数字方式显示在萤幕上。数位血压计将有助于节省时间。这将使患者无需向帮助您监测血压的医生支付不必要的费用。虽然大多数型号都是电池供电，但有些型号专为现场使用而设计，并具有双电源，包括太阳能和电池。

此外，数位血压计对于有听力或视力障碍的人来说是一个绝佳的选择。有些甚至提供纸本列印输出来帮助您保存记录。这有助于您的医生在下次预约时评估您的健康状况。因此，增加了对数位非侵入性血压计的需求。因此，从上述因素来看，该细分市场在预测期内占据了最大的市场份额。

无创血压计市场地理份额

北美地区在全球无创血压计市场中占有最大的市场份额

北美地区在2021年占据最大的市场份额。因素预测期内的成长。例如，根据美国疾病管制与预防中心的数据，高血压会增加心臟病和中风的风险，而心臟病和中风是美国的主要原因。 2020 年，高血压是美国超过 67 万人死亡的主要原因。不受控制的高血压影响约一半的成年人 (45%)，其血压为 140/90 mmHg 或更高。其中包括美国 3700 万成年人。

此外，2022年8月31日，Sensifree LTD获得了SentiCor-100符合新欧盟MDR的CE证书。 SentiCor-100 是世界上第一款获准在医院使用的基于 PPG 的连续非侵入性血压 (cNIBP) 监测设备。因此，从上述因素来看，北美地区在预测期内占据了最大的市场份额。

非侵入性血压计公司

非侵入性血压监测器市场的主要参与者包括 GE Healthcare、SOMNOmedics、Eccosur SA、Koninklijke Philips NV、Huntleigh Technology Ltd.、Mortara Instrument、Schiller Americans Inc.、American Diagnostic Corporation 和 Welch Allyn。

通用电气医疗保健：

概述 ：

GE医疗集团是美国跨国集团通用电气公司的子公司。截至 2017 年，该公司生产和分销用于医学成像程序中使用的成像模式的诊断成像剂和放射性药物。 GE Healthcare 也生产医疗诊断设备，包括 CT 影像机。此外，它还开发用于医学影像和资讯技术、医疗诊断、病患监测系统、疾病研究、药物发现和生物製药製造的健康技术。该公司业务遍及 100 多个国家。

产品组合：

CRITIKON SOFT-CUF 血压袖带：CRITIKON SOFT-CUF 由柔软、吸收性材料製成，具有圆角，可最大限度地提高患者在长期住院期间的舒适度。这些袖带非常适合长期住院的患者或袖带在患者整个住院期间随身携带的方案。它可以清洗并重复用于多个患者。儘管如此，它的价格仍然合理，因此可以在单一患者使用后丢弃，以更经济的方式预防感染。

全球无创血压监测仪市场报告将提供约。 45+市场资料表，40+图表，180页。

目录

第 1 章：方法与范围

第 2 章：市场定义与概述

第 3 章：执行摘要

第 4 章：市场动态

  • 市场影响因素
    • 司机
      • 正在进行的非侵入性血压监测仪研究预计将推动市场成长。
    • 限制：
      • 无创血压测量的缺点预计将阻碍市场成长。
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特的五力
  • 供应链
  • 定价分析

第 6 章：COVID-19 分析

第 7 章：按装置类型

  • 自动血压监测仪
  • 动态血压监测仪
  • 血压计
  • 血压感测器

第 8 章：按技术

  • 数位的
  • 无液
  • 穿戴式

第 9 章：按配件

  • 血压袖带
  • 压力计
  • 阀门和管道
  • 灯泡

第 10 章：按最终用户

  • 医院
  • 诊所
  • 门诊手术中心
  • 居家照护环境
  • 其他的

第 11 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • GE Healthcare
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务概览
  • SOMNOmedics
  • Eccosur SA
  • Koninklijke Philips NV
  • Huntleigh Technology Ltd.
  • Mortara Instrument
  • Schiller Americans Inc.
  • American Diagnostic Corporation
  • Welch Allyn(*LIST NOT EXHAUSTIVE)

第 14 章：数据M

简介目录
Product Code: MD56

Report Overview

The Global Non-Invasive Blood Pressure Monitors Market reached US$ 2,430.50 million in 2023 and is expected to reach US$ 5,353.15 million by 2031, growing at a CAGR of 10.71% during the forecast period 2024-2031.

Blood pressure monitors are used in hospitals to measure the blood pressure of patients who are critically ill or will be operated on for any surgical procedure. Blood pressure monitors are used in the operating room, intensive care units, surgical recovery rooms, emergency departments, and other critical care areas to measure blood pressure regularly or continuously. Blood pressure is checked during a patient's critical condition because it plays an important role in diagnosis.

Non-Invasive Blood Pressure Monitors Market Dynamics

The global rise of hypertension and cardiovascular diseases and governmental control, the rising geriatric population, and technological advancement in non-invasive blood pressure monitors are the factors to drive the market in the forecast period.

Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.

BPro (Healthstats, Singapore) is a wristwatch radial artery tonometer for ambulatory blood pressure measurement. It is calibrated with a brachial cuff device at first. The watch provides accurate results for at least 24 hours after calibration. The device comprises a watch head with a simple graphic user interface and a plunger to be pressed against the radial artery. The plunger is taped to the wrist by the healthcare professional performing the calibration to prevent it from moving while in use. The device has been validated by the AAMI and ESH standards, with SBP and DBP readings of (0.9 7.6) mmHg and (1.1 6.1) mmHg, respectively.

Furthermore, in 2020, a research group at the University of Turku proposed a tabletop form factor blood pressure instrument, the finger artery non-invasive tonooscillometric monitor (FANTOM). A tonometric cuffless mechatronic system is used to apply pressure to the fingertip and measure blood pressure using an oscillometric method. The device can measure arterial waveforms and central blood pressure (CBP). An arbitrary validation protocol comparing the device to an automated arm cuff monitor produced SBP and DBP results of (0.9 7.3) mmHg and (3.3 6.6) mmHg, respectively. Therefore, the ongoing research for cuffless non-invasive blood pressure monitors is expected to drive in the forecast period.

Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.

Non-invasive blood pressure measurement is less reliable at pressure extremes, and continuous monitoring is impossible; it can be painful if set to repeat too frequently and requires manual operation for maximum accuracy (i.e., automatic modes are unreliable in unstable patients). Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact on Non-Invasive Blood Pressure Monitors Market Growth

The COVID-19 pandemic has impacted the non-invasive blood pressure monitors market moderately. Experts realized that COVID-19 was especially dangerous for people with heart disease and related conditions, especially high blood pressure when cases of the virus started to rise globally. One hundred three million adults in the United States, or nearly half of all adults, have high blood pressure, also referred to as hypertension. Even more concerning is the fact that only 1 in 4 adults have their blood pressure under control. Uncontrolled blood pressure can result in severe complications like heart attack and stroke. As COVID-19 outbreaks persisted, a new issue surfaced. High blood pressure sufferers may be susceptible to more fatal and severe coronavirus side effects. As a result, there is now more of a demand for non-invasive blood pressure monitors.

In addition, COVID-19 has another potentially harmful effect. It has caused many patients to avoid local hospitals and emergency rooms because they might contract the coronavirus. Hospitals nationwide are reporting a decrease in visits for urgent medical needs. Still, some experts think this isn't because patients are experiencing fewer of them rather than because they are putting off or postponing seeking treatment. Thus, from the above factors, the market got affected and is expected to improve in the forecast period.

Non-Invasive Blood Pressure Monitors Market Segmentation

The digital segment is expected to hold the largest market share in non-invasive blood pressure monitors

The digital segment accounted for the largest market share in 2021. The convenience that a digital blood pressure monitor provides in its mode of operation. They are ideal for use at home, particularly if the patient takes blood pressure readings. They employ electronic pressure sensors to assist in the measurement of blood pressure. As a result, readings are displayed digitally on a screen. A digital blood pressure monitor will help save time. It will save the patient from paying unnecessary fees to doctors who help you monitor their blood pressure. While most are battery-powered, some models are designed for field use and have dual power sources, including solar and battery cells.

Furthermore, digital blood pressure monitors are an excellent choice for people who have hearing or vision impairments. Some even provide paper printouts to assist you in keeping records. This helps your doctor evaluate your health at your next appointment. Therefore, it has increased the demand for digital non-invasive blood pressure monitors. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Non-Invasive Blood Pressure Monitors Market Geographical Share

North America region holds the largest market share in the global non-invasive blood pressure monitors market

North America region accounted for the largest market share in 2021. The rising geriatric population, rising incidence of hypertension, increasing prevalence of cardiovascular disease, technological advancement in non-invasive blood pressure monitors, and product launches by the market players are the factors driving market growth in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Hypertension increases the risk of heart disease and stroke, which are the leading causes of death in the United States. Hypertension was a primary or contributing cause of more than 670,000 deaths in the United States in 2020. Only about one in every four adults (24%) has hypertension under control. Uncontrolled hypertension affects roughly half of all adults (45%), with a blood pressure of 140/90 mmHg or higher. This includes 37 million adults in the United States.

Furthermore, On August 31, 2022, Sensifree LTD received a CE certificate for SentiCor-100 in compliance with the new EU MDR. SentiCor-100 is the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Non-Invasive Blood Pressure Monitors Companies

Major key players in the non-invasive blood pressure monitors market are GE Healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd., Mortara Instrument, Schiller Americans Inc., American Diagnostic Corporation, and Welch Allyn.

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of the American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

Product Portfolio:

CRITIKON SOFT-CUF Blood Pressure Cuffs: CRITIKON SOFT-CUF is made of soft, absorbent material with rounded corners to maximize patient comfort during long hospital stays. These cuffs are ideal for patients with longer-term stays or protocols in which the cuff travels with the patient throughout their stay. It can be cleaned and reused on multiple patients. Still, it is reasonably priced so that it can be discarded after single-patient use, allowing for preventing infections more affordably.

The global non-invasive blood pressure Monitors market report would provide access to approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or a Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Automated BP Monitors*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Ambulatory BP Monitors
  • 7.4. Sphygmomanometers
  • 7.5. BP Transducers

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Aneroid
  • 8.4. Wearable

9. By Accessory

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 9.1.2. Market Attractiveness Index, By Accessory
  • 9.2. Blood Pressure Cuffs*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Manometers
  • 9.4. Valves and Tubing
  • 9.5. Bulbs

10. By End-user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Home Care Setting
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. SOMNOmedics
  • 13.3. Eccosur SA
  • 13.4. Koninklijke Philips N.V.
  • 13.5. Huntleigh Technology Ltd.
  • 13.6. Mortara Instrument
  • 13.7. Schiller Americans Inc.
  • 13.8. American Diagnostic Corporation
  • 13.9. Welch Allyn(*LIST NOT EXHAUSTIVE)

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us